Suchergebnisse - "Chang, C-Hong"

PubPharm (30)

1

BMPR1A promotes ID2-ZEB1 interaction to suppress excessive endothelial to mesenchymal transition

enthalten in: Cardiovascular research | 2023

von Lee, H. | Adachi, T. | Pak, B. | +15

2

Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection

enthalten in: bioRxiv.org | 2021

von Ma, L. | Sahu, S. | Cano, M. | +28

3

Clinically compatible advances in blood-derived endothelial progenitor cell isolation and reprogramming for translational applications

enthalten in: New biotechnology | 2021

von Eminli, S. | Kwieder, B. | Yi, K. | +7

4

Author Correction : Delayed production of neutralizing antibodies correlates with fatal COVID-19

enthalten in: Nature medicine | 2021

von Lucas, C. | Klein, J. | Sundaram, M. | +103

ErratumFor: Nat Med. 2021 Jul;27(7):1178-1186. - PMID 33953384

5

Delayed production of neutralizing antibodies correlates with fatal COVID-19

enthalten in: Nature medicine | 2021

von Lucas, C. | Klein, J. | Sundaram, M. | +103

ErratumIn: Nat Med. 2021 Jun 18;:. - PMID 34145437

6

A neutrophil activation signature predicts critical illness and mortality in COVID-19

enthalten in: Blood advances | 2021

von Meizlish, M. | Pine, A. | Bishai, J. | +27

UpdateOf: medRxiv. 2020 Sep 02;:. - PMID 32908988

7

Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection

enthalten in: bioRxiv : the preprint server for biology | 2021

von Ma, L. | Sahu, S. | Cano, M. | +28

UpdateIn: Sci Immunol. 2021 May 13;6(59):. - PMID 34446527

8

A neutrophil activation signature predicts critical illness and mortality in COVID-19

enthalten in: bioRxiv.org | 2021

von Meizlish, M. | Pine, A. | Bishai, J. | +27

9

Circulating Markers of Angiogenesis and Endotheliopathy in COVID-19

enthalten in: bioRxiv.org | 2021

von Meizlish, M. | Pine, A. | Goshua, G. | +14

10

Changes in inflammatory and immune drivers in response to immunomodulatory therapies in COVID-19

enthalten in: bioRxiv.org | 2020

von Wang, S. | Chang, C. | Meizlish, M. | +4